Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis

被引:60
作者
Baker, SS [1 ]
Borowitz, D [1 ]
Duffy, L [1 ]
Fitzpatrick, L [1 ]
Gyamfi, J [1 ]
Baker, RD [1 ]
机构
[1] SUNY Buffalo, Womens & Childrens Hosp Buffalo, Dept Pediat, Buffalo, NY 14260 USA
关键词
D O I
10.1016/j.jpeds.2004.09.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To assess the relationship between pancreatic enzyme therapy (PET) and the clinical outcomes of growth, abdominal pain, constipation, gassiness, and number of stools in cystic fibrosis (CF). Study design Patients (n = 1215) >4 weeks of age from 33 Cystic Fibrosis Foundation accredited sites who had a sweat chloride >60 mmol/L or two CF-causing mutations were enrolled using a proportionate sampling strategy in a nonblinded study. Patients submitted a stool sample and completed a questionnaire. The study coordinator also completed a questionnaire for each patient. Enzyme dosing and growth, abdominal pain, gassiness, constipation, and number of stools were compared. Results Of the 1215 enrolled patients, 1131 (93.1%) were prescribed PET. Only 14.9% had pancreatic function assessed before enrolling in this study. Stool elastase-1 analysis identified 1074 (89%) patients as pancreatic insufficient (PI). There was no association between PET and the outcomes: growth, abdominal pain, gassiness, constipation, and number of stools. Conclusion PET dose is not correlated with growth or gastrointestinal symptoms. More sensitive outcome measures of the effectiveness of PET in patients with CF are needed to guide treatment of PI.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 12 条
[1]   RECURRENT ABDOMINAL PAINS - A FIELD SURVEY OF 1,000 SCHOOL CHILDREN [J].
APLEY, J ;
NAISH, N .
ARCHIVES OF DISEASE IN CHILDHOOD, 1958, 33 (168) :165-170
[2]   Constipation in infants and children: Evaluation and treatment [J].
Baker, SS ;
Liptak, GS ;
Colletti, RB ;
Croffie, JM ;
Di Lorenzo, C ;
Ector, W ;
Nurko, S .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1999, 29 (05) :612-626
[3]   Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis [J].
Borowitz, D ;
Baker, SS ;
Duffy, L ;
Baker, RD ;
Fitzpatrick, L ;
Gyamfi, J ;
Jarembek, K .
JOURNAL OF PEDIATRICS, 2004, 145 (03) :322-326
[4]   USE OF PANCREATIC-ENZYME SUPPLEMENTS FOR PATIENTS WITH CYSTIC-FIBROSIS IN THE CONTEXT OF FIBROSING COLONOPATHY [J].
BOROWITZ, DS ;
GRAND, RJ ;
DURIE, PR ;
BEKER, LT ;
DODGE, JA ;
FINK, RJ ;
FITZSIMMONS, SC ;
FREIMAN, J ;
KALNINS, D ;
KIMURA, R ;
KIRSCHNER, B ;
LLOYDSTILL, JD ;
LOWENFELS, A ;
MAGUINESS, K ;
ROBERTS, IM ;
SCHWARZENBERG, SJ ;
SMYTH, RL ;
STEVENS, JC ;
STONE, RT ;
THOMPSON, B ;
VANVELZEN, D ;
WEST, K ;
ZERIN, JM .
JOURNAL OF PEDIATRICS, 1995, 127 (05) :681-684
[5]   Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis [J].
Durno, C ;
Corey, M ;
Zielenski, J ;
Tullis, E ;
Tsui, LC ;
Durie, P .
GASTROENTEROLOGY, 2002, 123 (06) :1857-1864
[6]   Abdominal pain and irritable bowel syndrome in adolescents: A community-based study [J].
Hyams, JS ;
Burke, G ;
Davis, PM ;
Rzepski, B ;
Andrulonis, PA .
JOURNAL OF PEDIATRICS, 1996, 129 (02) :220-226
[7]  
KUCZMARSKI RJ, 2000, 2000 CDC GROWTH CHAR
[8]   Constipation in children [J].
Loening-Baucke, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (16) :1155-1156
[9]  
RASQUINWEBER A, GUT, V45, pII60
[10]  
RUBINSTEIN S, 1986, PEDIATRICS, V78, P473